Wolters Kluwer Health, Pharma Solutions

Adis International Recognized for its Strong Dedication to Employee Development

    Chester, England (ots/PRNewswire) -

    - Accepts Prestigious 2004 'Investors in People' Award

    Wolters Kluwer Health, Pharma Solutions business unit today announced that Adis International was named a 2004 "Investor in People" by the Investors in People UK Recognition Panel. The London-based organization assesses corporate business practices against a national standard and recognizes only those companies that meet or exceed those requirements.

    The Adis offices in Chester, Oxford and London were recognized for a superior commitment to supporting the development of its people. A full-scale assessment, which included interviews with 31 employees, determined that the company had moved forward, improved methods of communication and forged a "very positive attitude and atmosphere from staff."

    "The development of our people is of paramount importance to us," said Peter George, EVP of Europe and Asia Pacific. "It is also completely in line with our business objective to always strive for improvement. To be a guiding force tomorrow, we must invest in our people today."

    "Investors in People" is a national standard that sets out a level of good practice for training and development of people to achieve business goals. The standard provides a national framework for improving business performance and competitiveness, through a planned approach to setting and communicating business objectives and developing people to meet these objectives.

    The Investors in People (UK) program was established in 1993 to provide national ownership of the Investors in People Standard and is responsible for its promotion and branding, quality assurance and development. Since 1991, tens of thousands of UK employers have become involved with the standard.

    As part of Wolters Kluwer Health, Pharma Solutions business unit, Adis International is one of the preeminent information providers to the pharmaceutical and biotechnology markets. Adis journals are among the most-cited publications in their respective fields, and provide a unique blend of original articles, authoritative reviews, profiles, and drug evaluations.

    For more information about the Investors in People program, visit http://www.iipuk.co.uk. For more about Adis and Wolters Kluwer Health, Pharma Solutions, visit http://www.wkhealth.com or http://www.adis.com.

    About Wolters Kluwer Health

    The Wolters Kluwer Health Pharma Solutions division provides information and communications support for the pharmaceutical industry, from drug discovery and research to launch and marketing under the industry's leading medical information brands, Adis International, IFI Claims and Lippincott Williams & Wilkins.

    Wolters Kluwer Health is a unit of WoltersKluwer nv, a leading multinational publisher and information services company with annual revenues (2003) of euro 3.4 billion and employing approximately 18,750 people worldwide. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its depositary receipts of shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.

    For more information, visit http://www.adis.com and http://www.wkhealth.com

      Contact: Tom Kivett
      Kivett & Company Communications
      +1-212-727-2935
      tkivett@kivettandco.com
      Web site: http://www.wkhealth.com
                      http://www.adis.com
                      http://www.iipuk.co.uk

ots Originaltext: Wolters Kluwer Health, Pharma Solutions
Im Internet recherchierbar: http://www.newsaktuell.ch

Contact:
Tom Kivett of Kivett & Company Communications, +1-212-727-2935,
tkivett@kivettandco.com, for Wolters Kluwer Health, Pharma Solutions



Weitere Meldungen: Wolters Kluwer Health, Pharma Solutions

Das könnte Sie auch interessieren: